Schnabel, L.V., Sonea HO, Jacobson MS, Fortier LA. Effects of platelet rich plasma and acellular bone marrow
on gene expression patterns and DNA content of equine suspensory ligament explant cultures. Equine Vet J,
2008; 40(3):260-265.
Smith RKS, Werling NJ, Dakin SJ, Alam R, Hughes T, Crawford A, Fiske-Jackson A, Goodship AE and Dudhia
J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring equine
tendinopathy. PLoS One. 2013 Sep 25;8(9):e75697
Smith, J.J., M.W. Ross, and R.K. Smith, Anabolic effects of acellular bone marrow, platelet rich plasma, and
serum on equine suspensory ligament fibroblasts in vitro. Vet Comp Orthop Traumatol, 2006; 19(1):43-47.
Smith, R.K., et al., Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow
into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J. 2003; 35(1):99-102.
Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the
cellular composition of platelet-rich plasma. Am J Sports Med. 2011; 39(10):2135-2140.
Textor JA and Tablin F. Intra-Articular Use of a Platelet-Rich Product in Normal Horses. Veterinary Surgery
2013; 42:499–510.
Waselau M, Sutter WW, Genovese RL, Bertone AL. Intralesional injection of platelet-rich plasma followed by
controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses. J Am
Vet Med Assoc 2008; 232:1515–1520.
15-‐18
February
2016
East
London
Convention
Centre,
East
London,
South
Africa
185